Overview
- Apple is partnering with U.S.-based startup Synchron to integrate brain-computer interface (BCI) technology into its devices, including the Vision Pro, iPhone, and iPad.
- The collaboration will introduce a new BCI protocol in 2025 updates for iPadOS, iOS, and visionOS, enabling neural signal input across Apple’s ecosystem.
- Synchron’s stentrode implant uses a minimally invasive procedure via the jugular vein to record neural signals, reducing scarring and improving signal reliability.
- This technology aims to provide accessibility to tens of thousands of users with severe motor impairments, such as those with spinal cord injuries or ALS.
- Apple and Synchron are working to establish an industry-wide standard for BCI integration, building on Apple’s history of accessibility innovations like Bluetooth hearing aid protocols.